Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alpinia oxyphylla oil is a natural botanical extract derived from the seeds or fruits of *Alpinia oxyphylla* Miquel, a perennial herb in the Zingiberaceae family with a long history of use in traditional Chinese medicine. The oil is a complex mixture of volatile compounds, primarily sesquiterpenes and other terpenoids. Preclinical research has demonstrated its potential therapeutic effects in hepatocellular carcinoma (HCC) by inhibiting the PI3K/Akt signaling pathway and inducing apoptosis. Additionally, it has shown neuroprotective and antidepressant-like activities, potentially through the modulation of the TLR4/MyD88/NF-κB pathway, cholinergic balance, and serotonergic signaling. While it has been studied by various academic institutions in China, it has not yet advanced to clinical trials as a regulated pharmaceutical product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alpinia oxyphylla oil.